| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.029 | 0.9 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.0045 | 0.9 |